Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 1385 - 1392 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC5783 | pep4c |
|
Inactive control peptide analog of pep2m, a peptide inhibitor of the interaction between the C-terminus of the GluR2 (AMPA receptor) subunit and N-ethylmaleimide-sensitive fusion protein (NSF).
|
|
| BCC5784 | pep2-SVKI |
|
Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluR2 AMPA receptor subunit. Disrupts binding of GluR2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases amplitude of AMPA receptor-mediated currents and blocks long-term depression (LTD). Control peptide available.
|
|
| BCC5785 | pep2-SVKE |
|
Inactive control peptide analog of pep2-SVKI, an inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluR2 AMPA receptor subunit.
|
|
| BCC5786 | pep2-EVKI |
|
Inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).
|
|
| BCC5787 | pep2-AVKI |
|
Inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).
|
|
| BCC5788 | Urocortin (human) |
|
Endogenous CRF agonist. K<sub>i</sub> values are 0.4, 0.3 and 0.5 nM for hCRF<sub>1</sub>, rCRF<sub>2</sub><sub><span class='symbol'>α</span></sub> and mCRF<sub>2</sub><sub><span class='symbol'>β</span></sub> respectively.
|
|
| BCC5789 | Urocortin (rat) |
|
Endogenous CRF agonist. K<sub>i</sub> values are 13, 1.5 and 0.97 nM for hCRF<sub>1</sub>, rCRF<sub>2</sub><sub><span class='symbol'>α</span></sub> and mCRF<sub>2</sub><sub><span class='symbol'>β</span></sub> respectively.
|
|
| BCC5790 | Astressin |
|
Potent corticotropin-releasing factor (CRF) receptor antagonist (K<sub>i</sub> values are 2, 1.5 and 1 nM at CRF<sub>1</sub>, CRF<sub>2</sub><sub><span class='symbol'>α</span></sub> and CRF<sub>2</sub><sub><span class='symbol'>β</span></sub>). Reduces ACTH secretion, blocks delayed gastric emptying and is neuroprotective <em>in vivo</em>.
|
|